Product Description
Insulin Glargine is a synthetic long-acting basal insulin analog. It features stable slow release, no obvious peak effect, provides 24-hour continuous basal insulin supply. It effectively controls fasting blood glucose, reduces nocturnal hypoglycemia risk, suitable for long-term daily glucose regulation in diabetic patients. Cartridge design matches insulin pen for convenient subcutaneous injection.
Indications
- Treatment of Type 1 Diabetes Mellitus
- Treatment of Type 2 Diabetes Mellitus
- Gestational diabetes poorly controlled by diet and exercise
- Long-term basal blood sugar maintenance therapy
Administration
- Route: Subcutaneous injection only
- Usual dose: Once daily, same time every day
- Administer by insulin pen with 3ml cartridge
- Dosage individualized based on blood glucose, weight and clinical condition, follow doctor’s prescription strictly
- Not for intravenous or intramuscular injection
Product Features
- Standard strength: 100 IU/mL, 3ml cartridge
- 24-hour long-acting stable basal glucose control
- Flat time-action profile, low hypoglycemia risk
- Convenient cartridge form, compatible with reusable insulin pens
- Reliable efficacy, stable quality for long-term diabetes management
Storage
- Unopened: Store at 2–8°C, refrigerate, do not freeze
- In-use: Store below 25°C, away from direct sunlight and heat, use within recommended period
- Avoid freezing and high temperature exposure
Warnings
- Prescription-only hypoglycemic biological preparation, use strictly under physician guidance.
- Contraindicated in patients hypersensitive to insulin glargine or excipients.
- Risk of hypoglycemia; patients should master blood glucose monitoring and emergency management.
- Do not arbitrarily adjust dose or injection time.
- Keep out of reach of children.
